COVID-19 Impact on Global Anti-thrombin III Testing Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: CB798429B9AAEN
QYResearch

Abstracts

This report focuses on the global Anti-thrombin III Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-thrombin III Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott Laboratories
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.
• ...

Market segment by Type, the product can be split into

• Diagnosis of antithrombin deficiency
• Activity assays
• Immunological assays

Market segment by Application, split into

• Hospital
• Research institute
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Anti-thrombin III Testing status, future forecast, growth opportunity, key market and key players.
• To present the Anti-thrombin III Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anti-thrombin III Testing are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-thrombin III Testing Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anti-thrombin III Testing Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Diagnosis of antithrombin deficiency
  1.4.3 Activity assays
  1.4.4 Immunological assays
1.5 Market by Application
  1.5.1 Global Anti-thrombin III Testing Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Research institute
  1.5.4 Clinic
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Anti-thrombin III Testing Industry Impact
  1.6.1 How the Covid-19 is Affecting the Anti-thrombin III Testing Industry
    1.6.1.1 Anti-thrombin III Testing Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Anti-thrombin III Testing Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Anti-thrombin III Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anti-thrombin III Testing Market Perspective (2015-2026)
2.2 Anti-thrombin III Testing Growth Trends by Regions
  2.2.1 Anti-thrombin III Testing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anti-thrombin III Testing Historic Market Share by Regions (2015-2020)
  2.2.3 Anti-thrombin III Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anti-thrombin III Testing Market Growth Strategy
  2.3.6 Primary Interviews with Key Anti-thrombin III Testing Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anti-thrombin III Testing Players by Market Size
  3.1.1 Global Top Anti-thrombin III Testing Players by Revenue (2015-2020)
  3.1.2 Global Anti-thrombin III Testing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anti-thrombin III Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-thrombin III Testing Market Concentration Ratio
  3.2.1 Global Anti-thrombin III Testing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anti-thrombin III Testing Revenue in 2019
3.3 Anti-thrombin III Testing Key Players Head office and Area Served
3.4 Key Players Anti-thrombin III Testing Product Solution and Service
3.5 Date of Enter into Anti-thrombin III Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anti-thrombin III Testing Historic Market Size by Type (2015-2020)
4.2 Global Anti-thrombin III Testing Forecasted Market Size by Type (2021-2026)

5 ANTI-THROMBIN III TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anti-thrombin III Testing Market Size by Application (2015-2020)
5.2 Global Anti-thrombin III Testing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anti-thrombin III Testing Market Size (2015-2020)
6.2 Anti-thrombin III Testing Key Players in North America (2019-2020)
6.3 North America Anti-thrombin III Testing Market Size by Type (2015-2020)
6.4 North America Anti-thrombin III Testing Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anti-thrombin III Testing Market Size (2015-2020)
7.2 Anti-thrombin III Testing Key Players in Europe (2019-2020)
7.3 Europe Anti-thrombin III Testing Market Size by Type (2015-2020)
7.4 Europe Anti-thrombin III Testing Market Size by Application (2015-2020)

8 CHINA

8.1 China Anti-thrombin III Testing Market Size (2015-2020)
8.2 Anti-thrombin III Testing Key Players in China (2019-2020)
8.3 China Anti-thrombin III Testing Market Size by Type (2015-2020)
8.4 China Anti-thrombin III Testing Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anti-thrombin III Testing Market Size (2015-2020)
9.2 Anti-thrombin III Testing Key Players in Japan (2019-2020)
9.3 Japan Anti-thrombin III Testing Market Size by Type (2015-2020)
9.4 Japan Anti-thrombin III Testing Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Anti-thrombin III Testing Market Size (2015-2020)
10.2 Anti-thrombin III Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-thrombin III Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-thrombin III Testing Market Size by Application (2015-2020)

11 INDIA

11.1 India Anti-thrombin III Testing Market Size (2015-2020)
11.2 Anti-thrombin III Testing Key Players in India (2019-2020)
11.3 India Anti-thrombin III Testing Market Size by Type (2015-2020)
11.4 India Anti-thrombin III Testing Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Anti-thrombin III Testing Market Size (2015-2020)
12.2 Anti-thrombin III Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-thrombin III Testing Market Size by Type (2015-2020)
12.4 Central & South America Anti-thrombin III Testing Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Anti-thrombin III Testing Introduction
  13.1.4 Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 Danaher Corp.
  13.2.1 Danaher Corp. Company Details
  13.2.2 Danaher Corp. Business Overview and Its Total Revenue
  13.2.3 Danaher Corp. Anti-thrombin III Testing Introduction
  13.2.4 Danaher Corp. Revenue in Anti-thrombin III Testing Business (2015-2020)
  13.2.5 Danaher Corp. Recent Development
13.3 F. Hoffmann-La Roche Ltd.
  13.3.1 F. Hoffmann-La Roche Ltd. Company Details
  13.3.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  13.3.3 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Introduction
  13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2015-2020)
  13.3.5 F. Hoffmann-La Roche Ltd. Recent Development
13.4 Siemens Healthcare GmbH
  13.4.1 Siemens Healthcare GmbH Company Details
  13.4.2 Siemens Healthcare GmbH Business Overview and Its Total Revenue
  13.4.3 Siemens Healthcare GmbH Anti-thrombin III Testing Introduction
  13.4.4 Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2015-2020)
  13.4.5 Siemens Healthcare GmbH Recent Development
13.5 Thermo Fisher Scientific Inc.
  13.5.1 Thermo Fisher Scientific Inc. Company Details
  13.5.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
  13.5.3 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Introduction
  13.5.4 Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2015-2020)
  13.5.5 Thermo Fisher Scientific Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anti-thrombin III Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-thrombin III Testing Revenue
Table 3. Ranking of Global Top Anti-thrombin III Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-thrombin III Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnosis of antithrombin deficiency
Table 6. Key Players of Activity assays
Table 7. Key Players of Immunological assays
Table 8. COVID-19 Impact Global Market: (Four Anti-thrombin III Testing Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Anti-thrombin III Testing Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Anti-thrombin III Testing Players to Combat Covid-19 Impact
Table 13. Global Anti-thrombin III Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Anti-thrombin III Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Anti-thrombin III Testing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Anti-thrombin III Testing Market Share by Regions (2015-2020)
Table 17. Global Anti-thrombin III Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Anti-thrombin III Testing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Anti-thrombin III Testing Market Growth Strategy
Table 23. Main Points Interviewed from Key Anti-thrombin III Testing Players
Table 24. Global Anti-thrombin III Testing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Anti-thrombin III Testing Market Share by Players (2015-2020)
Table 26. Global Top Anti-thrombin III Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-thrombin III Testing as of 2019)
Table 27. Global Anti-thrombin III Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Anti-thrombin III Testing Product Solution and Service
Table 30. Date of Enter into Anti-thrombin III Testing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Anti-thrombin III Testing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Anti-thrombin III Testing Market Size Share by Type (2015-2020)
Table 34. Global Anti-thrombin III Testing Revenue Market Share by Type (2021-2026)
Table 35. Global Anti-thrombin III Testing Market Size Share by Application (2015-2020)
Table 36. Global Anti-thrombin III Testing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Anti-thrombin III Testing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Anti-thrombin III Testing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Anti-thrombin III Testing Market Share (2019-2020)
Table 40. North America Anti-thrombin III Testing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Anti-thrombin III Testing Market Share by Type (2015-2020)
Table 42. North America Anti-thrombin III Testing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Anti-thrombin III Testing Market Share by Application (2015-2020)
Table 44. Europe Key Players Anti-thrombin III Testing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Anti-thrombin III Testing Market Share (2019-2020)
Table 46. Europe Anti-thrombin III Testing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Anti-thrombin III Testing Market Share by Type (2015-2020)
Table 48. Europe Anti-thrombin III Testing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Anti-thrombin III Testing Market Share by Application (2015-2020)
Table 50. China Key Players Anti-thrombin III Testing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Anti-thrombin III Testing Market Share (2019-2020)
Table 52. China Anti-thrombin III Testing Market Size by Type (2015-2020) (Million US$)
Table 53. China Anti-thrombin III Testing Market Share by Type (2015-2020)
Table 54. China Anti-thrombin III Testing Market Size by Application (2015-2020) (Million US$)
Table 55. China Anti-thrombin III Testing Market Share by Application (2015-2020)
Table 56. Japan Key Players Anti-thrombin III Testing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Anti-thrombin III Testing Market Share (2019-2020)
Table 58. Japan Anti-thrombin III Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Anti-thrombin III Testing Market Share by Type (2015-2020)
Table 60. Japan Anti-thrombin III Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Anti-thrombin III Testing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Anti-thrombin III Testing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Anti-thrombin III Testing Market Share (2019-2020)
Table 64. Southeast Asia Anti-thrombin III Testing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Anti-thrombin III Testing Market Share by Type (2015-2020)
Table 66. Southeast Asia Anti-thrombin III Testing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Anti-thrombin III Testing Market Share by Application (2015-2020)
Table 68. India Key Players Anti-thrombin III Testing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Anti-thrombin III Testing Market Share (2019-2020)
Table 70. India Anti-thrombin III Testing Market Size by Type (2015-2020) (Million US$)
Table 71. India Anti-thrombin III Testing Market Share by Type (2015-2020)
Table 72. India Anti-thrombin III Testing Market Size by Application (2015-2020) (Million US$)
Table 73. India Anti-thrombin III Testing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Anti-thrombin III Testing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Anti-thrombin III Testing Market Share (2019-2020)
Table 76. Central & South America Anti-thrombin III Testing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Anti-thrombin III Testing Market Share by Type (2015-2020)
Table 78. Central & South America Anti-thrombin III Testing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Anti-thrombin III Testing Market Share by Application (2015-2020)
Table 80. Abbott Laboratories Company Details
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Product
Table 83. Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2015-2020) (Million US$)
Table 84. Abbott Laboratories Recent Development
Table 85. Danaher Corp. Company Details
Table 86. Danaher Corp. Business Overview
Table 87. Danaher Corp. Product
Table 88. Danaher Corp. Revenue in Anti-thrombin III Testing Business (2015-2020) (Million US$)
Table 89. Danaher Corp. Recent Development
Table 90. F. Hoffmann-La Roche Ltd. Company Details
Table 91. F. Hoffmann-La Roche Ltd. Business Overview
Table 92. F. Hoffmann-La Roche Ltd. Product
Table 93. F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2015-2020) (Million US$)
Table 94. F. Hoffmann-La Roche Ltd. Recent Development
Table 95. Siemens Healthcare GmbH Company Details
Table 96. Siemens Healthcare GmbH Business Overview
Table 97. Siemens Healthcare GmbH Product
Table 98. Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2015-2020) (Million US$)
Table 99. Siemens Healthcare GmbH Recent Development
Table 100. Thermo Fisher Scientific Inc. Company Details
Table 101. Thermo Fisher Scientific Inc. Business Overview
Table 102. Thermo Fisher Scientific Inc. Product
Table 103. Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2015-2020) (Million US$)
Table 104. Thermo Fisher Scientific Inc. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anti-thrombin III Testing Market Share by Type: 2020 VS 2026
Figure 2. Diagnosis of antithrombin deficiency Features
Figure 3. Activity assays Features
Figure 4. Immunological assays Features
Figure 5. Global Anti-thrombin III Testing Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Research institute Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Anti-thrombin III Testing Report Years Considered
Figure 11. Global Anti-thrombin III Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Anti-thrombin III Testing Market Share by Regions: 2020 VS 2026
Figure 13. Global Anti-thrombin III Testing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Anti-thrombin III Testing Market Share by Players in 2019
Figure 16. Global Top Anti-thrombin III Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-thrombin III Testing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Anti-thrombin III Testing Revenue in 2019
Figure 18. North America Anti-thrombin III Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Anti-thrombin III Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Anti-thrombin III Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Anti-thrombin III Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Anti-thrombin III Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Anti-thrombin III Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Anti-thrombin III Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbott Laboratories Revenue Growth Rate in Anti-thrombin III Testing Business (2015-2020)
Figure 27. Danaher Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Danaher Corp. Revenue Growth Rate in Anti-thrombin III Testing Business (2015-2020)
Figure 29. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anti-thrombin III Testing Business (2015-2020)
Figure 31. Siemens Healthcare GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Siemens Healthcare GmbH Revenue Growth Rate in Anti-thrombin III Testing Business (2015-2020)
Figure 33. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Thermo Fisher Scientific Inc. Revenue Growth Rate in Anti-thrombin III Testing Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed